Neuberger Berman Group’s Axsome Therapeutics AXSM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.37M | Buy |
+70,632
| New | +$7.37M | 0.01% | 860 |
|
|
2024
Q4 | – | Sell |
-80,014
| Closed | -$7.19M | – | 1929 |
|
|
2024
Q3 | $7.19M | Buy |
80,014
+5,247
| +7% | +$472K | 0.01% | 860 |
|
|
2024
Q2 | $6.02M | Sell |
74,767
-16,889
| -18% | -$1.36M | ﹤0.01% | 866 |
|
|
2024
Q1 | $7.31M | Buy |
91,656
+47,341
| +107% | +$3.78M | 0.01% | 849 |
|
|
2023
Q4 | $3.53M | Buy |
+44,315
| New | +$3.53M | ﹤0.01% | 994 |
|
|
2020
Q4 | – | Sell |
-34,500
| Closed | -$2.46M | – | 1664 |
|
|
2020
Q3 | $2.46M | Buy |
34,500
+7,000
| +25% | +$499K | ﹤0.01% | 1025 |
|
|
2020
Q2 | $2.26M | Buy |
27,500
+11,000
| +67% | +$905K | ﹤0.01% | 982 |
|
|
2020
Q1 | $971K | Sell |
16,500
-3,500
| -18% | -$206K | ﹤0.01% | 1101 |
|
|
2019
Q4 | $2.07M | Sell |
20,000
-12,900
| -39% | -$1.33M | ﹤0.01% | 1023 |
|
|
2019
Q3 | $666K | Buy |
32,900
+3,500
| +12% | +$70.9K | ﹤0.01% | 1219 |
|
|
2019
Q2 | $757K | Sell |
29,400
-12,600
| -30% | -$324K | ﹤0.01% | 1205 |
|
|
2019
Q1 | $598K | Buy |
+42,000
| New | +$598K | ﹤0.01% | 1211 |
|